Calendrier des promotions BioMarin Pharmaceutical
Calendrier avancé
Graphique simple
À propos de l'entreprise BioMarin Pharmaceutical
BioMarin Pharmaceutical Inc. — американская биотехнологическая компания со штаб-квартирой в Сан-Рафаэле, Калифорния . У него есть офисы и помещения в США , Южной Америке , Азии и Европе . Основным направлением деятельности и исследованиями BioMarin является заместительная терапия ферментами (ФЗТ). plus de détailsParamètres de base
IPO date
1999-07-23
ISIN
US09061G1013
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
0
Сайт
Grade
Sous-estimation
Nom | Signification | Grade |
P/S | 4.51 | 3 |
P/BV | 2.28 | 6 |
P/E | 30.16 | 5 |
Efficacité
Nom | Signification | Grade |
ROA | 6.17 | 2 |
ROE | 8.05 | 3 |
ROIC | 0.79 | 1 |
Dividendes
Nom | Signification | Grade |
Rendement en dividendes | 0 | 0 |
DSI | 0 | 0 |
Croissance moyenne du dividende | 0 | 0 |
Devoir
Nom | Signification | Grade |
Debt/EBITDA | 0.9265 | 9 |
Debt/Ratio | 0.0862 | 10 |
Debt/Equity | 0.2352 | 10 |
Impulsion de croissance
Nom | Signification | Grade |
Rentabilité Revenue, % | 53.44 | 7 |
Rentabilité Ebitda, % | -11125.9 | 0 |
Rentabilité EPS, % | -51.56 | 0 |
paper.price.prices
Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
common.calendar.number_days.1 | 57.28 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
common.calendar.number_days.7d | 56.65 $ | 57.16 $ | 57.28 $ | 1.11 % | 0 % | 0 % |
common.calendar.number_days.30d | 58.01 $ | 55.27 $ | 59.93 $ | -1.26 % | 0 % | 0 % |
common.calendar.number_days.90d | 59.43 $ | 55.27 $ | 72.83 $ | -3.62 % | 0 % | 0 % |
common.calendar.number_days.180d | 62.87 $ | 55.27 $ | 72.83 $ | -8.89 % | 0 % | 0 % |
common.calendar.number_days.1y | 90.46 $ | 55.27 $ | 93.84 $ | -36.68 % | 0 % | 0 % |
common.calendar.number_days.3y | 89.02 $ | 55.27 $ | 117.27 $ | -35.65 % | 0 % | 0 % |
common.calendar.number_days.5y | 78.74 $ | 55.27 $ | 131.03 $ | -27.25 % | 0 % | 0 % |
common.calendar.number_days.10y | 81.38 $ | 55.27 $ | 149.09 $ | -29.61 % | 0 % | 0 % |
common.calendar.number_days.ytd | 64.42 $ | 55.27 $ | 72.83 $ | -11.08 % | 0 % | 0 % |
Délit d'initié
Principaux propriétaires
Contenu dans l'ETF
ETF | Partager, % | Rentabilité pour l'année, % | Commission, % |
VictoryShares Nasdaq Next 50 ETF | 1.38305 | 3.94 | 0.18 |
iShares Evolved U.S. Innovative Healthcare ETF | 1.35 | 0.000586 | 0.18 |
Future Tech ETF | 1.30612 | -18.13 | 0.35 |
Principal Healthcare Innovators ETF | 1.30612 | -3.92 | 0.35 |
IQ Engender Equality ETF | 1.03522 | 7.62 | 0.45 |
GraniteShares XOUT U.S. Large Cap ETF | 0.86381 | -25.71 | 0.60 |
Syntax Stratified MidCap ETF | 0.34133 | -1.54 | 0.35 |
iShares Morningstar Mid-Cap Growth ETF | 0.24673 | 441.88 | 0.06 |
iShares Morningstar Mid-Cap ETF | 0.12333 | 252.83 | 0.04 |
iShares Morningstar Large-Cap Growth ETF | 0.05463 | 264.7 | 0.04 |
iShares Morningstar Large-Cap ETF | 0.0266 | 184.21 | 0.03 |
Columbia U.S. ESG Equity Income ETF | 0.02348 | -3.6 | 0.35 |
0,67 | 91,86 | 0,25 |
---|
Entreprises similaires
P/E & P/BV
Gestion d'entreprise
Superviseur | Titre d'emploi | Paiement | Année de naissance |
Mr. Brian R. Mueller | CFO & Executive VP | 1.15M | 1974 (51 année) |
Mr. George Eric Davis | Executive VP, Chief Legal Officer, General Counsel & Secretary | 1.23M | 1971 (54 année) |
Ms. Erin Burkhart | Group VP & Chief Accounting Officer | N/A | 1979 (46 années) |
Mr. Alexander Hardy | President, CEO & Director | N/A | 1969 (56 années) |
Dr. C. Greg Guyer Ph.D. | Executive VP & CTO | 1962 (63 année) | |
Dr. Kevin Eggan Ph.D. | Chief Scientific Officer & Senior VP of Research and Early Development | ||
Traci McCarty | Group Vice President of Investor Relations | ||
Ms. Humaira Serajuddin | Senior VP & Chief Marketing Officer | ||
Ms. Amy Wireman | Executive VP & Chief People Officer |
Informations sur l'entreprise
Adresse: United States, San Rafael, 770 Lindaro Street - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: http://www.biomarin.com
Site web: http://www.biomarin.com